Vitamin E, an antioxidant, improves insulin sensitivity through the suppression of conventional PKC in vascular smooth muscle cells. It has been reported that vitamin E reduces platelet aggregation through the suppression of PKCalpha and beta (Diabetes 47 (1998) 1494). On the other hand, 1alpha.25-dihydroxy vitamin D3 (1,25D3) activates conventional PKC and may subsequently cause insulin resistance. Against this background, we examined the effect of vitamin E and 1.25D3 on PKCbeta and PKC zeta/lambda activities in vitro and 10 nM insulin-induced glucose uptake in rat adipocytes. In vitro PKCbeta activity of adipocytes was slightly decreased by the addition of 1 muM vitamin E, but not PKC zeta/lambda activity. In contrast, a 10-1000 nM 1,25133 dose responsively activated PKCbeta activity of adipocytes (ED 50%. 10 nM), but not PKC zeta/lambda activity. Pretreatment with 1 muM vitamin E for 60 min did not improve the insulin-induced glucose uptake. On the other hand. pretreatment with a 10-1000 nM 1.25D3 dose responsively suppressed insulin-induced glucose uptake. Moreover, 1.25D3 increased membrane-associated PKCbeta immunoreactivity for 60 min, but no additional increase in membrane-associated PKCbeta immunoreactivity during treatment with insulin was observed. These results suggest that 1.25D3 reduces insulin-induced glucose uptake via activation of PKCbeta, but not vitamin E in rat adipocytes. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.